[250 Pages Report] Global L-Lysine Hydrochloride (HCL)’ demand is anticipated to be valued at USD 240.6 Million in 2022, forecast to grow at a CAGR of 4.2% to be valued at USD 341.7 Million from 2022 to 2032. Growth is attributed to the rising mouth related problems and injuries.
| Report Attribute | Details |
|---|---|
| Growth Rate (2016 to 2021) | 3.1% CAGR |
| Expected Market Value (2022) | USD 240.6 Million |
| Anticipated Forecast Value (2032) | USD 341.7 Million |
| Projected Growth Rate (2022 to 2032) | 4.2% CAGR |
L-Lysine HCL is a revolutionary white color powder that heals human body and provides essential nutrition to it. It is an essential amino acid for humans and must be supplied in the diet at 12mg per Kg of human body weight. Almost all the foods available on our planet have sufficient amount of L-Lysine HCL which makes it abundant on the planet and easy to be extracted.
L-Lysine HCL is commonly used to treat mouth and genital lesions caused by herpes simplex virus. Taking L-Lysine HCL can speed up the recovery from herpes infection. Also, it is used in curing shingles caused by herpes zoster viruses. The human body does not produce L-Lysine HCL because of which it needs to be taken by diet or supplement.
Factors such as an increase in consumption of meat and beef are expected to boost the L-Lysine Hydrochloride (HCL) Market growth during the forecast period.
On the other hand, people born with higher level of lysine in the blood suffer from a disorder called hyperlysinemia, which is expected to hamper the growth of L-Lysine Hydrochloride (HCL) Market over the analysis period.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The increasing applications for curing various diseases in human body is one of the major factors that is expected to augment the growth of the L-Lysine Hydrochloride (HCL) market during the forecast period.
Protein powder, vitamins and mineral drinks, processed meat, breakfast cereals and other processed foods will be responsible for L-Lysine HCL demand in future. Apart from processed food, its medicinal use will drive the market growth because of its increasing applications in curing diseases.
Rising mouth related problems and injuries, rising accident level, increasing osteoporosis cases are the primary drivers for L-Lysine HCL market. L-Lysine HCL is commonly consumed in powder form and tablets. Animal food, especially for pigs, chicken, goat, and sheep, cow and buffalo, contains L-Lysine HCL which are expected to accelerate the market growth in forthcoming years.
L-Lysine HCL market has an opportunity towards the advancements in the area of processed food and animal food which will give pace to the market growth of L-Lysine HCL for next ten years. L-Lysine HCL will be heavily used in healthcare as an alternative medicine for curing many diseases that will boost the market in future. All these factors are anticipated to escalate the growth of the L-Lysine Hydrochloride (HCL) Market over the analysis period.
L-Lysine Hydrochloride (HCL) might increase the level of Aminoglycoside toxicity, effects patients with liver and kidney impairment, and can cause an adverse reaction in gastrointestinal diseases such as diarrhea, nausea, and abdominal pain. In some cases, Fanconi syndrome and tubulointerstitial nephritis are developed when L-Lysine HCL is taken for consecutive five years. This is one of the major factors that is expected to impede the growth of the L-Lysine Hydrochloride (HCL) market during the forecast period.
Additionally, people born with higher level of lysine in the blood suffer from a disorder called hyperlysinemia. Hyperlysinemia is a metabolic disorder that is caused by increase of lysine in the blood. Common symptoms of hyperlysinemia include fatigue, anemia, and hair loss. This factor, in turn, is expected to act as a restrain for the market growth in the forthcoming years.
In terms of regional platform, North America holds the largest market share in L-Lysine Hydrochloride (HCL) market. The region is expected to surge at over 32.6% share from 2022 to 2032.
North America is expected to fuel the L-Lysine Hydrochloride (HCL) market, attributed to the increasing cases of osteoporosis in the region.
According to Future Market Insights, Europe is expected to hold significant growth opportunities for L-Lysine Hydrochloride (HCL), and is expected to reach at a market share of 27.5% in 2022.
Europe is expected to witness a significant market growth, owing to the rising mouth related problems and injuries in the region.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
According to Future Market Insights, Asia-Pacific is expected to grow with lucrative growth opportunities for L-Lysine Hydrochloride (HCL) Market, and is expected to reach at a significant share of 24.4% in 2022.
Asia-Pacific region accounts for a significant share in L-Lysine Hydrochloride (HCL) Market, attributed to the large consumer base and investment in pet food market. The market in India and China are still at growth stage which are expected to flourish the growth of the L-Lysine Hydrochloric (HCL) Market during the forecast period.
According to Future Market Insights, Middle East & Africa is expected to provide significant growth opportunities for L-Lysine Hydrochloride (HCL) Market, and is expected to reach at a share of 10.3% in 2022.
The developing L-Lysine Hydrochloride (HCL) market in the Middle East & Africa is expected to aid in flourishing market during the forecast period, owing to increasing awareness regarding the L-Lysine Hydrochloric (HCL) in the region.
There are many prominent market players in the L-Lysine Hydrochloride (HCL) Market such as, Evonik Industries AG, CJ Bio, ADM, Global Bio-chem Technology, EPPEN Biotech, Meihua Group, COFCO Biochemical, Fagron, Senova, Menadiona, Otto Brandes, Xintai Jiahe Biotech, Kyowa, and Tianjin Tianyao, among others, that are working hand-in-hand to provide the best-in-class L-Lysine Hydrochloride (HCL) for enhancing the global arena. However, there are many global start-ups in the L-Lysine Hydrochloride (HCL) Market, that are stepping forward in matching the requirements of the L-Lysine Hydrochloride (HCL) domain.
Some of the key participants present in the global L-Lysine Hydrochloride (HCL) market include TCI Chemicals (India) Pvt. Ltd., Merck KGaA, Ajinomoto, GeneLinx International, Inc., Shandong Shouguang Juneng Golden Corn Co., Ltd., and TCI (Shanghai) Chemical Industry Development Co., Ltd., among others.
Attributed to the presence of such high number of participants, the market is highly competitive. While global players such as Ajinomoto, CJ Bio, ADM, Global Bio-chem Technology, EPPEN Biotech, Meihua Group, COFCO Biochemical, Fagron, and Senova account for a considerable market size, several regional level players are also operating across key growth regions, particularly in North America.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 4.2% from 2022 to 2032 |
| Market Value in 2022 | USD 240.6 Million |
| Market Value in 2032 | USD 341.7 Million |
| Base Year for Estimation | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Source, Application, Region |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; APEJ; Japan; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, Belgium, Netherlands, Luxembourg, Poland, Russia, Australia & New Zealand, China, India, ASEAN, GCC, South Africa |
| Key Companies Profiled | Ajinomoto; CJ Bio; ADM Global Bio-chem Technology; EPPEN Biotech; Meihua Group; COFCO Biochemical; Fagron; Senova; Menadiona; Otto Brandes; Xintai Jiahe Biotech; Kyowa; and Tianjin Tianyao; among others. |
| Customization | Available Upon Request |
FMI projects the global L-Lysine Hydrochloride (HCL) market to expand at an 4.2% value CAGR by 2032
North America is expected to be the most opportunistic L-Lysine Hydrochloride (HCL) market, expanding at a 32.6% market share
Ajinomoto, CJ Bio, ADM, Global Bio-chem Technology, EPPEN Biotech, Meihua Group, COFCO Biochemical, Fagron, and Senova are some prominent L-Lysine Hydrochloride (HCL) players
| Market Estimated Size in 2024 | USD 651.6 million |
|---|---|
| Projected Market Value in 2034 | USD 5,709.8 million |
| Value-based CAGR (2024 to 2034) | 24.2% |
| Expected Market Value (2023) | USD 498.2 million |
|---|---|
| Anticipated Forecast Value (2033) | USD 798.8 million |
| Projected Growth Rate (2023 to 2033) | 4.8% |
| Market Size (2022) | USD 2043.66 million |
|---|---|
| Market Size (2032) | USD 2565.46 million |
| Market CAGR (2022 to 2032) | 2.3% |
Explore Functional Food Ingredients Insights
View Reports
L-Lysine Hydrochloride (HCL) Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
